TheEdgeResearch
Home / Stocks / TECH

Bio-Techne Corporation (TECH)

NASDAQ Healthcare Biotechnology
$54.00 ▼ -0.04%
Market Cap
$8.45B
Sector
Healthcare
Industry
Biotechnology
Beta
1.36
52-Wk Range
43.2-72.16
CEO
Kim Kelderman
Country
US
Currency
USD

Bio-Techne Corporation, headquartered in Minneapolis, Minnesota, is a global enterprise specializing in the development, production, and distribution of specialized life science tools, instrumentation, and support solutions for both research and clinical diagnostic markets. The company is organized into two key business units: Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment manufactures a broad array of biological components, including cytokines, growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies, which are instrumenta…

Open full interactive analysis & DCF →